[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Montelukast Market Research Report 2020

September 2020 | 118 pages | ID: GED1B145C673EN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Montelukast market is segmented into
  • Montelukast Amorphous
  • Montelukast Crystalline
Segment by Application
  • Tablets
  • Chewable Tablet
  • Oral Solution
Global Montelukast Market: Regional Analysis
The Montelukast market is analysed and market size information is provided by regions (countries).
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Montelukast market report are:
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Taiwan
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • U.A.E
Global Montelukast Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Montelukast market include:
  • Morepen Laboratories
  • Mylan
  • TAPI
  • MSN Laboratories
  • Ultratech India
  • Aurobindo Pharma
  • Hetero Labs
  • Unimark Remedies
  • Jubilant Cadista
  • Aamorb Pharmaceuticals
  • Sudarshan Groups
  • Ortin Laboratories
  • Vamsi Labs
  • Adley Group
  • Medopharm
  • Hengyuan Pharmaceutical
  • Arromax Pharmaceutical Technology
  • Lihe Wuhan New Chemical Materials
  • Shanghai Huachu Chemical
1 MONTELUKAST MARKET OVERVIEW

1.1 Product Overview and Scope of Montelukast
1.2 Montelukast Segment by Type
  1.2.1 Global Montelukast Sales Growth Rate Comparison by Type (2021-2026)
  1.2.2 Montelukast Amorphous
  1.2.3 Montelukast Crystalline
1.3 Montelukast Segment by Application
  1.3.1 Montelukast Sales Comparison by Application: 2020 VS 2026
  1.3.2 Tablets
  1.3.3 Chewable Tablet
  1.3.4 Oral Solution
1.4 Global Montelukast Market Size Estimates and Forecasts
  1.4.1 Global Montelukast Revenue 2015-2026
  1.4.2 Global Montelukast Sales 2015-2026
  1.4.3 Montelukast Market Size by Region: 2020 Versus 2026
1.5 Montelukast Industry
1.6 Montelukast Market Trends

2 GLOBAL MONTELUKAST MARKET COMPETITION BY MANUFACTURERS

2.1 Global Montelukast Sales Market Share by Manufacturers (2015-2020)
2.2 Global Montelukast Revenue Share by Manufacturers (2015-2020)
2.3 Global Montelukast Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Montelukast Manufacturing Sites, Area Served, Product Type
2.5 Montelukast Market Competitive Situation and Trends
  2.5.1 Montelukast Market Concentration Rate
  2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Montelukast Players (Opinion Leaders)

3 MONTELUKAST RETROSPECTIVE MARKET SCENARIO BY REGION

3.1 Global Montelukast Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Montelukast Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Montelukast Market Facts & Figures by Country
  3.3.1 North America Montelukast Sales by Country
  3.3.2 North America Montelukast Sales by Country
  3.3.3 U.S.
  3.3.4 Canada
3.4 Europe Montelukast Market Facts & Figures by Country
  3.4.1 Europe Montelukast Sales by Country
  3.4.2 Europe Montelukast Sales by Country
  3.4.3 Germany
  3.4.4 France
  3.4.5 U.K.
  3.4.6 Italy
  3.4.7 Russia
3.5 Asia Pacific Montelukast Market Facts & Figures by Region
  3.5.1 Asia Pacific Montelukast Sales by Region
  3.5.2 Asia Pacific Montelukast Sales by Region
  3.5.3 China
  3.5.4 Japan
  3.5.5 South Korea
  3.5.6 India
  3.5.7 Australia
  3.5.8 Taiwan
  3.5.9 Indonesia
  3.5.10 Thailand
  3.5.11 Malaysia
  3.5.12 Philippines
  3.5.13 Vietnam
3.6 Latin America Montelukast Market Facts & Figures by Country
  3.6.1 Latin America Montelukast Sales by Country
  3.6.2 Latin America Montelukast Sales by Country
  3.6.3 Mexico
  3.6.3 Brazil
  3.6.3 Argentina
3.7 Middle East and Africa Montelukast Market Facts & Figures by Country
  3.7.1 Middle East and Africa Montelukast Sales by Country
  3.7.2 Middle East and Africa Montelukast Sales by Country
  3.7.3 Turkey
  3.7.4 Saudi Arabia
  3.7.5 U.A.E

4 GLOBAL MONTELUKAST HISTORIC MARKET ANALYSIS BY TYPE

4.1 Global Montelukast Sales Market Share by Type (2015-2020)
4.2 Global Montelukast Revenue Market Share by Type (2015-2020)
4.3 Global Montelukast Price Market Share by Type (2015-2020)
4.4 Global Montelukast Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 GLOBAL MONTELUKAST HISTORIC MARKET ANALYSIS BY APPLICATION

5.1 Global Montelukast Sales Market Share by Application (2015-2020)
5.2 Global Montelukast Revenue Market Share by Application (2015-2020)
5.3 Global Montelukast Price by Application (2015-2020)

6 COMPANY PROFILES AND KEY FIGURES IN MONTELUKAST BUSINESS

6.1 Morepen Laboratories
  6.1.1 Corporation Information
  6.1.2 Morepen Laboratories Description, Business Overview and Total Revenue
  6.1.3 Morepen Laboratories Montelukast Sales, Revenue and Gross Margin (2015-2020)
  6.1.4 Morepen Laboratories Products Offered
  6.1.5 Morepen Laboratories Recent Development
6.2 Mylan
  6.2.1 Mylan Corporation Information
  6.2.2 Mylan Description, Business Overview and Total Revenue
  6.2.3 Mylan Montelukast Sales, Revenue and Gross Margin (2015-2020)
  6.2.4 Mylan Products Offered
  6.2.5 Mylan Recent Development
6.3 TAPI
  6.3.1 TAPI Corporation Information
  6.3.2 TAPI Description, Business Overview and Total Revenue
  6.3.3 TAPI Montelukast Sales, Revenue and Gross Margin (2015-2020)
  6.3.4 TAPI Products Offered
  6.3.5 TAPI Recent Development
6.4 MSN Laboratories
  6.4.1 MSN Laboratories Corporation Information
  6.4.2 MSN Laboratories Description, Business Overview and Total Revenue
  6.4.3 MSN Laboratories Montelukast Sales, Revenue and Gross Margin (2015-2020)
  6.4.4 MSN Laboratories Products Offered
  6.4.5 MSN Laboratories Recent Development
6.5 Ultratech India
  6.5.1 Ultratech India Corporation Information
  6.5.2 Ultratech India Description, Business Overview and Total Revenue
  6.5.3 Ultratech India Montelukast Sales, Revenue and Gross Margin (2015-2020)
  6.5.4 Ultratech India Products Offered
  6.5.5 Ultratech India Recent Development
6.6 Aurobindo Pharma
  6.6.1 Aurobindo Pharma Corporation Information
  6.6.2 Aurobindo Pharma Description, Business Overview and Total Revenue
  6.6.3 Aurobindo Pharma Montelukast Sales, Revenue and Gross Margin (2015-2020)
  6.6.4 Aurobindo Pharma Products Offered
  6.6.5 Aurobindo Pharma Recent Development
6.7 Hetero Labs
  6.6.1 Hetero Labs Corporation Information
  6.6.2 Hetero Labs Description, Business Overview and Total Revenue
  6.6.3 Hetero Labs Montelukast Sales, Revenue and Gross Margin (2015-2020)
  6.4.4 Hetero Labs Products Offered
  6.7.5 Hetero Labs Recent Development
6.8 Unimark Remedies
  6.8.1 Unimark Remedies Corporation Information
  6.8.2 Unimark Remedies Description, Business Overview and Total Revenue
  6.8.3 Unimark Remedies Montelukast Sales, Revenue and Gross Margin (2015-2020)
  6.8.4 Unimark Remedies Products Offered
  6.8.5 Unimark Remedies Recent Development
6.9 Jubilant Cadista
  6.9.1 Jubilant Cadista Corporation Information
  6.9.2 Jubilant Cadista Description, Business Overview and Total Revenue
  6.9.3 Jubilant Cadista Montelukast Sales, Revenue and Gross Margin (2015-2020)
  6.9.4 Jubilant Cadista Products Offered
  6.9.5 Jubilant Cadista Recent Development
6.10 Aamorb Pharmaceuticals
  6.10.1 Aamorb Pharmaceuticals Corporation Information
  6.10.2 Aamorb Pharmaceuticals Description, Business Overview and Total Revenue
  6.10.3 Aamorb Pharmaceuticals Montelukast Sales, Revenue and Gross Margin (2015-2020)
  6.10.4 Aamorb Pharmaceuticals Products Offered
  6.10.5 Aamorb Pharmaceuticals Recent Development
6.11 Sudarshan Groups
  6.11.1 Sudarshan Groups Corporation Information
  6.11.2 Sudarshan Groups Montelukast Description, Business Overview and Total Revenue
  6.11.3 Sudarshan Groups Montelukast Sales, Revenue and Gross Margin (2015-2020)
  6.11.4 Sudarshan Groups Products Offered
  6.11.5 Sudarshan Groups Recent Development
6.12 Ortin Laboratories
  6.12.1 Ortin Laboratories Corporation Information
  6.12.2 Ortin Laboratories Montelukast Description, Business Overview and Total Revenue
  6.12.3 Ortin Laboratories Montelukast Sales, Revenue and Gross Margin (2015-2020)
  6.12.4 Ortin Laboratories Products Offered
  6.12.5 Ortin Laboratories Recent Development
6.13 Vamsi Labs
  6.13.1 Vamsi Labs Corporation Information
  6.13.2 Vamsi Labs Montelukast Description, Business Overview and Total Revenue
  6.13.3 Vamsi Labs Montelukast Sales, Revenue and Gross Margin (2015-2020)
  6.13.4 Vamsi Labs Products Offered
  6.13.5 Vamsi Labs Recent Development
6.14 Adley Group
  6.14.1 Adley Group Corporation Information
  6.14.2 Adley Group Montelukast Description, Business Overview and Total Revenue
  6.14.3 Adley Group Montelukast Sales, Revenue and Gross Margin (2015-2020)
  6.14.4 Adley Group Products Offered
  6.14.5 Adley Group Recent Development
6.15 Medopharm
  6.15.1 Medopharm Corporation Information
  6.15.2 Medopharm Montelukast Description, Business Overview and Total Revenue
  6.15.3 Medopharm Montelukast Sales, Revenue and Gross Margin (2015-2020)
  6.15.4 Medopharm Products Offered
  6.15.5 Medopharm Recent Development
6.16 Hengyuan Pharmaceutical
  6.16.1 Hengyuan Pharmaceutical Corporation Information
  6.16.2 Hengyuan Pharmaceutical Montelukast Description, Business Overview and Total Revenue
  6.16.3 Hengyuan Pharmaceutical Montelukast Sales, Revenue and Gross Margin (2015-2020)
  6.16.4 Hengyuan Pharmaceutical Products Offered
  6.16.5 Hengyuan Pharmaceutical Recent Development
6.17 Arromax Pharmaceutical Technology
  6.17.1 Arromax Pharmaceutical Technology Corporation Information
  6.17.2 Arromax Pharmaceutical Technology Montelukast Description, Business Overview and Total Revenue
  6.17.3 Arromax Pharmaceutical Technology Montelukast Sales, Revenue and Gross Margin (2015-2020)
  6.17.4 Arromax Pharmaceutical Technology Products Offered
  6.17.5 Arromax Pharmaceutical Technology Recent Development
6.18 Lihe Wuhan New Chemical Materials
  6.18.1 Lihe Wuhan New Chemical Materials Corporation Information
  6.18.2 Lihe Wuhan New Chemical Materials Montelukast Description, Business Overview and Total Revenue
  6.18.3 Lihe Wuhan New Chemical Materials Montelukast Sales, Revenue and Gross Margin (2015-2020)
  6.18.4 Lihe Wuhan New Chemical Materials Products Offered
  6.18.5 Lihe Wuhan New Chemical Materials Recent Development
6.19 Shanghai Huachu Chemical
  6.19.1 Shanghai Huachu Chemical Corporation Information
  6.19.2 Shanghai Huachu Chemical Montelukast Description, Business Overview and Total Revenue
  6.19.3 Shanghai Huachu Chemical Montelukast Sales, Revenue and Gross Margin (2015-2020)
  6.19.4 Shanghai Huachu Chemical Products Offered
  6.19.5 Shanghai Huachu Chemical Recent Development

7 MONTELUKAST MANUFACTURING COST ANALYSIS

7.1 Montelukast Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Key Raw Materials Price Trend
  7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Montelukast
7.4 Montelukast Industrial Chain Analysis

8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS

8.1 Marketing Channel
8.2 Montelukast Distributors List
8.3 Montelukast Customers

9 MARKET DYNAMICS

9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 GLOBAL MARKET FORECAST

10.1 Global Montelukast Market Estimates and Projections by Type
  10.1.1 Global Forecasted Sales of Montelukast by Type (2021-2026)
  10.1.2 Global Forecasted Revenue of Montelukast by Type (2021-2026)
10.2 Montelukast Market Estimates and Projections by Application
  10.2.1 Global Forecasted Sales of Montelukast by Application (2021-2026)
  10.2.2 Global Forecasted Revenue of Montelukast by Application (2021-2026)
10.3 Montelukast Market Estimates and Projections by Region
  10.3.1 Global Forecasted Sales of Montelukast by Region (2021-2026)
  10.3.2 Global Forecasted Revenue of Montelukast by Region (2021-2026)
10.4 North America Montelukast Estimates and Projections (2021-2026)
10.5 Europe Montelukast Estimates and Projections (2021-2026)
10.6 Asia Pacific Montelukast Estimates and Projections (2021-2026)
10.7 Latin America Montelukast Estimates and Projections (2021-2026)
10.8 Middle East and Africa Montelukast Estimates and Projections (2021-2026)

11 RESEARCH FINDING AND CONCLUSION

12 METHODOLOGY AND DATA SOURCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

LIST OF TABLES

Table 1. Global Montelukast Sales (Kiloton) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Montelukast Sales (Kiloton) Comparison by Application: 2020 VS 2026
Table 3. Global Montelukast Market Size by Type (Kiloton) (US$ Million) (2020 VS 2026)
Table 4. Global Key Montelukast Manufacturers Covered in This Study
Table 5. Global Montelukast Sales (Kiloton) by Manufacturers (2015-2020)
Table 6. Global Montelukast Sales Share by Manufacturers (2015-2020)
Table 7. Global Montelukast Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Montelukast Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Montelukast Average Price (US$/Ton) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Montelukast Sales Sites and Area Served
Table 11. Manufacturers Montelukast Product Types
Table 12. Global Montelukast Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Montelukast by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Montelukast as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Montelukast Players
Table 16. Global Montelukast Sales (Kiloton) by Region (2015-2020)
Table 17. Global Montelukast Sales Market Share by Region (2015-2020)
Table 18. Global Montelukast Revenue (Million US$) by Region (2015-2020)
Table 19. Global Montelukast Revenue Market Share by Region (2015-2020)
Table 20. North America Montelukast Sales by Country (2015-2020) (Kiloton)
Table 21. North America Montelukast Sales Market Share by Country (2015-2020)
Table 22. North America Montelukast Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Montelukast Revenue Market Share by Country (2015-2020)
Table 24. Europe Montelukast Sales by Country (2015-2020) (Kiloton)
Table 25. Europe Montelukast Sales Market Share by Country (2015-2020)
Table 26. Europe Montelukast Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Montelukast Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Montelukast Sales by Region (2015-2020) (Kiloton)
Table 29. Asia Pacific Montelukast Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Montelukast Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Montelukast Revenue Market Share by Region (2015-2020)
Table 32. Latin America Montelukast Sales by Country (2015-2020) (Kiloton)
Table 33. Latin America Montelukast Sales Market Share by Country (2015-2020)
Table 34. Latin America Montelukast Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Montelukast Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Montelukast Sales by Country (2015-2020) (Kiloton)
Table 37. Middle East and Africa Montelukast Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Montelukast Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Montelukast Revenue Market Share by Country (2015-2020)
Table 40. Global Montelukast Sales (Kiloton) by Type (2015-2020)
Table 41. Global Montelukast Sales Share by Type (2015-2020)
Table 42. Global Montelukast Revenue (Million US$) by Type (2015-2020)
Table 43. Global Montelukast Revenue Share by Type (2015-2020)
Table 44. Global Montelukast Price (US$/Ton) by Type (2015-2020)
Table 45. Global Montelukast Sales (Kiloton) by Application (2015-2020)
Table 46. Global Montelukast Sales Market Share by Application (2015-2020)
Table 47. Global Montelukast Sales Growth Rate by Application (2015-2020)
Table 48. Morepen Laboratories Montelukast Corporation Information
Table 49. Morepen Laboratories Description and Business Overview
Table 50. Morepen Laboratories Montelukast Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 51. Morepen Laboratories Main Product
Table 52. Morepen Laboratories Recent Development
Table 53. Mylan Montelukast Corporation Information
Table 54. Mylan Corporation Information
Table 55. Mylan Montelukast Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 56. Mylan Main Product
Table 57. Mylan Recent Development
Table 58. TAPI Montelukast Corporation Information
Table 59. TAPI Corporation Information
Table 60. TAPI Montelukast Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 61. TAPI Main Product
Table 62. TAPI Recent Development
Table 63. MSN Laboratories Montelukast Corporation Information
Table 64. MSN Laboratories Corporation Information
Table 65. MSN Laboratories Montelukast Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 66. MSN Laboratories Main Product
Table 67. MSN Laboratories Recent Development
Table 68. Ultratech India Montelukast Corporation Information
Table 69. Ultratech India Corporation Information
Table 70. Ultratech India Montelukast Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 71. Ultratech India Main Product
Table 72. Ultratech India Recent Development
Table 73. Aurobindo Pharma Montelukast Corporation Information
Table 74. Aurobindo Pharma Corporation Information
Table 75. Aurobindo Pharma Montelukast Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 76. Aurobindo Pharma Main Product
Table 77. Aurobindo Pharma Recent Development
Table 78. Hetero Labs Montelukast Corporation Information
Table 79. Hetero Labs Corporation Information
Table 80. Hetero Labs Montelukast Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 81. Hetero Labs Main Product
Table 82. Hetero Labs Recent Development
Table 83. Unimark Remedies Montelukast Corporation Information
Table 84. Unimark Remedies Corporation Information
Table 85. Unimark Remedies Montelukast Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 86. Unimark Remedies Main Product
Table 87. Unimark Remedies Recent Development
Table 88. Jubilant Cadista Montelukast Corporation Information
Table 89. Jubilant Cadista Corporation Information
Table 90. Jubilant Cadista Montelukast Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 91. Jubilant Cadista Main Product
Table 92. Jubilant Cadista Recent Development
Table 93. Aamorb Pharmaceuticals Montelukast Corporation Information
Table 94. Aamorb Pharmaceuticals Corporation Information
Table 95. Aamorb Pharmaceuticals Montelukast Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 96. Aamorb Pharmaceuticals Main Product
Table 97. Aamorb Pharmaceuticals Recent Development
Table 98. Sudarshan Groups Montelukast Corporation Information
Table 99. Sudarshan Groups Corporation Information
Table 100. Sudarshan Groups Montelukast Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 101. Sudarshan Groups Main Product
Table 102. Sudarshan Groups Recent Development
Table 103. Ortin Laboratories Montelukast Corporation Information
Table 104. Ortin Laboratories Corporation Information
Table 105. Ortin Laboratories Montelukast Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 106. Ortin Laboratories Main Product
Table 107. Ortin Laboratories Recent Development
Table 108. Vamsi Labs Montelukast Corporation Information
Table 109. Vamsi Labs Corporation Information
Table 110. Vamsi Labs Montelukast Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 111. Vamsi Labs Main Product
Table 112. Vamsi Labs Recent Development
Table 113. Adley Group Montelukast Corporation Information
Table 114. Adley Group Corporation Information
Table 115. Adley Group Montelukast Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 116. Adley Group Main Product
Table 117. Adley Group Recent Development
Table 118. Medopharm Montelukast Corporation Information
Table 119. Medopharm Corporation Information
Table 120. Medopharm Montelukast Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 121. Medopharm Main Product
Table 122. Medopharm Recent Development
Table 123. Hengyuan Pharmaceutical Montelukast Corporation Information
Table 124. Hengyuan Pharmaceutical Corporation Information
Table 125. Hengyuan Pharmaceutical Montelukast Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 126. Hengyuan Pharmaceutical Main Product
Table 127. Hengyuan Pharmaceutical Recent Development
Table 128. Arromax Pharmaceutical Technology Montelukast Corporation Information
Table 129. Arromax Pharmaceutical Technology Corporation Information
Table 130. Arromax Pharmaceutical Technology Montelukast Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 131. Arromax Pharmaceutical Technology Main Product
Table 132. Arromax Pharmaceutical Technology Recent Development
Table 133. Lihe Wuhan New Chemical Materials Montelukast Corporation Information
Table 134. Lihe Wuhan New Chemical Materials Corporation Information
Table 135. Lihe Wuhan New Chemical Materials Montelukast Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 136. Lihe Wuhan New Chemical Materials Main Product
Table 137. Lihe Wuhan New Chemical Materials Recent Development
Table 138. Shanghai Huachu Chemical Montelukast Corporation Information
Table 139. Shanghai Huachu Chemical Corporation Information
Table 140. Shanghai Huachu Chemical Montelukast Sales (Kiloton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2015-2020)
Table 141. Shanghai Huachu Chemical Main Product
Table 142. Shanghai Huachu Chemical Recent Development
Table 143. Sales Base and Market Concentration Rate of Raw Material
Table 144. Key Suppliers of Raw Materials
Table 145. Montelukast Distributors List
Table 146. Montelukast Customers List
Table 147. Market Key Trends
Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 149. Key Challenges
Table 150. Global Montelukast Sales (Kiloton) Forecast by Type (2021-2026)
Table 151. Global Montelukast Sales Market Share Forecast by Type (2021-2026)
Table 152. Global Montelukast Revenue (Million US$) Forecast by Type (2021-2026)
Table 153. Global Montelukast Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 154. Global Montelukast Sales (Kiloton) Forecast by Application (2021-2026)
Table 155. Global Montelukast Revenue (Million US$) Forecast by Application (2021-2026)
Table 156. Global Montelukast Sales (Kiloton) Forecast by Region (2021-2026)
Table 157. Global Montelukast Sales Market Share Forecast by Region (2021-2026)
Table 158. Global Montelukast Revenue Forecast by Region (2021-2026) (US$ Million)
Table 159. Global Montelukast Revenue Market Share Forecast by Region (2021-2026)
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Picture of Montelukast
Figure 2. Global Montelukast Sales Market Share by Type: 2020 VS 2026
Figure 3. Montelukast Amorphous Product Picture
Figure 4. Montelukast Crystalline Product Picture
Figure 5. Global Montelukast Consumption Market Share by Application: 2020 VS 2026
Figure 6. Tablets
Figure 7. Chewable Tablet
Figure 8. Oral Solution
Figure 9. Global Montelukast Market Size 2015-2026 (US$ Million)
Figure 10. Global Montelukast Sales Capacity (Kiloton) (2015-2026)
Figure 11. Global Montelukast Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Montelukast Sales Share by Manufacturers in 2020
Figure 13. Global Montelukast Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Montelukast Revenue in 2019
Figure 15. Montelukast Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Montelukast Sales Market Share by Region (2015-2020)
Figure 17. Global Montelukast Sales Market Share by Region in 2019
Figure 18. Global Montelukast Revenue Market Share by Region (2015-2020)
Figure 19. Global Montelukast Revenue Market Share by Region in 2019
Figure 20. North America Montelukast Sales Market Share by Country in 2019
Figure 21. North America Montelukast Revenue Market Share by Country in 2019
Figure 22. U.S. Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 23. U.S. Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 25. Canada Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Montelukast Sales Market Share by Country in 2019
Figure 27. Europe Montelukast Revenue Market Share by Country in 2019
Figure 28. Germany Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 29. Germany Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 31. France Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 33. U.K. Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 35. Italy Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 37. Russia Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Montelukast Sales Market Share by Region in 2019
Figure 39. Asia Pacific Montelukast Revenue Market Share by Region in 2019
Figure 40. China Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 41. China Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 43. Japan Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 45. South Korea Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 47. India Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 49. Australia Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 51. Taiwan Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 53. Indonesia Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 55. Thailand Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 57. Malaysia Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 59. Philippines Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 61. Vietnam Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Montelukast Sales Market Share by Country in 2019
Figure 63. Latin America Montelukast Revenue Market Share by Country in 2019
Figure 64. Mexico Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 65. Mexico Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 67. Brazil Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 69. Argentina Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Montelukast Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Montelukast Revenue Market Share by Country in 2019
Figure 72. Turkey Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 73. Turkey Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 75. Saudi Arabia Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Montelukast Sales Growth Rate (2015-2020) (Kiloton)
Figure 77. U.A.E Montelukast Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Montelukast by Type (2015-2020)
Figure 79. Sales Market Share of Montelukast by Type in 2019
Figure 80. Revenue Share of Montelukast by Type (2015-2020)
Figure 81. Revenue Market Share of Montelukast by Type in 2019
Figure 82. Global Montelukast Sales Growth by Type (2015-2020) (Kiloton)
Figure 83. Global Montelukast Sales Market Share by Application (2015-2020)
Figure 84. Global Montelukast Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Montelukast by Application (2015-2020)
Figure 86. Global Revenue Share of Montelukast by Application in 2020
Figure 87. Morepen Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. TAPI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. MSN Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Ultratech India Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Hetero Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Unimark Remedies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Jubilant Cadista Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Aamorb Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Sudarshan Groups Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Ortin Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Vamsi Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Adley Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Medopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Hengyuan Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Arromax Pharmaceutical Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Lihe Wuhan New Chemical Materials Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Shanghai Huachu Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 106. Price Trend of Key Raw Materials
Figure 107. Manufacturing Cost Structure of Montelukast
Figure 108. Manufacturing Process Analysis of Montelukast
Figure 109. Montelukast Industrial Chain Analysis
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Porter's Five Forces Analysis
Figure 113. North America Montelukast Sales (Kiloton) and Growth Rate Forecast (2021-2026)
Figure 114. North America Montelukast Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Europe Montelukast Sales (Kiloton) and Growth Rate Forecast (2021-2026)
Figure 116. Europe Montelukast Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Latin America Montelukast Sales (Kiloton) and Growth Rate Forecast (2021-2026)
Figure 118. Latin America Montelukast Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Middle East and Africa Montelukast Sales (Kiloton) and Growth Rate Forecast (2021-2026)
Figure 120. Middle East and Africa Montelukast Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 121. Asia Pacific Montelukast Sales (Kiloton) and Growth Rate Forecast (2021-2026)
Figure 122. Asia Pacific Montelukast Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed


More Publications